原发性手掌多汗症患者的选择性T3交感神经切断术。
The selective T3 sympathicotomy in patients with essential palmar hyperhidrosis.
作者信息
Yoon S-H, Rim D-C
机构信息
Department of Neurosurgery, Inha University Hospital, College of Medicine, Inha University, Incheon, Korea.
出版信息
Acta Neurochir (Wien). 2003 Jun;145(6):467-71; discussion 471. doi: 10.1007/s00701-003-0011-8.
BACKGROUND
Selective T3 thoracoscopic sympathicotomy in patients with essential palmar hyperhidrosis may produce successful results with fewer side effects. We report preliminary results in comparison with those of conventional T2, T3 thoracoscopic sympathicotomy.
METHODS
Twenty-four patients underwent a conventional T2, T3 sympathicotomy (group A) from Jan 1997 to Dec 1997 and 30 patients a selective T3 sympathicotomy (group B) from Jan 1998 to Dec 1999. To assess postoperative success and complications all patient charts were reviewed.
FINDINGS
No recurrence was observed in either group. However, the rates of compensatory sweating were significantly (p=0.020) different: 11 patients (45.8%) in group A and 5 patients (16.73%) in group B. Horner's syndrome was observed in only 4 patients of group A.
INTERPRETATION
Selective T3 thoracoscopic sympathicotomy results in a decrease in the rate of disturbing side effects compared to conventional T2, T3 thoracoscopic sympathicotomy without recurrence of symptoms. We suggest that selective T3 thoracoscopic sympathicotomy is the treatment of choice in essential palmar hyperhidrosis.
背景
对于原发性掌部多汗症患者，选择性T3胸交感神经切断术可能会取得成功的治疗效果，且副作用较少。我们报告了与传统T2、T3胸交感神经切断术相比的初步结果。
方法
1997年1月至1997年12月，24例患者接受了传统T2、T3交感神经切断术（A组）；1998年1月至1999年12月，30例患者接受了选择性T3交感神经切断术（B组）。为评估术后效果及并发症，查阅了所有患者的病历。
结果
两组均未观察到复发情况。然而，代偿性出汗的发生率存在显著差异（p = 0.020）：A组有11例患者（45.8%），B组有5例患者（16.73%）。仅A组有4例患者出现霍纳综合征。
结论
与传统T2、T3胸交感神经切断术相比，选择性T3胸交感神经切断术可降低令人困扰的副作用发生率，且症状无复发。我们认为选择性T3胸交感神经切断术是原发性掌部多汗症的首选治疗方法。
Zotero 插件